patients responded course autologous vaccination respond booster vaccination need road planned maintenance therapy prevent relapse big challenge looming ahead personalized cancer immunotherapy disease adaptability cancers evolve response therapy haber says promising targeted therapies limited development drug resistance novel attacks cancer end arms race controlling cancer rests clinicians ability monitor changes patients treatment disease resistant catching quickly changing strategy difference patient prognosis trying develop new therapies based treatments look like coming decade nearly impossible task points joint head cancer genome project professor cancer genetics university london institute cancer research working developing finely targeted cancer treatments identifying oncogene 2002 10th anniversary human